Lactobacillus paracasei
Selected indexed studies
- Lactobacillus paracasei ZJUZ2-3 inhibits gastrointestinal tumors via the IAA-induced AHR/MTDH/NF-κB axis. (Int J Biol Sci, 2025) [PMID:41208900]
- Effectiveness of a Novel Food Composed of Leucine, Omega-3 Fatty Acids and Probiotic Lactobacillus paracasei PS23 for the Treatment of Sarcopenia in Elderly Subjects: A 2-Month Randomized Double-Blind Placebo-Controlled Trial. (Nutrients, 2022) [PMID:36364828]
- Genomics analysis of Lactobacillus paracasei SLP16. (Lett Appl Microbiol, 2022) [PMID:35526150]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lactobacillus paracasei ZJUZ2-3 inhibits gastrointestinal tumors via the IAA-induced AHR/MTDH/NF-κB axis. (2025) pubmed
- Effectiveness of a Novel Food Composed of Leucine, Omega-3 Fatty Acids and Probiotic Lactobacillus paracasei PS23 for the Treatment of Sarcopenia in Elderly Subjects: A 2-Month Randomized Double-Blind Placebo-Controlled Trial. (2022) pubmed
- Genomics analysis of Lactobacillus paracasei SLP16. (2022) pubmed
- Lactobacillus paracasei-derived extracellular vesicles reverse molecular and behavioral deficits in mouse models of autism spectrum disorder. (2025) pubmed
- Lactobacillus paracasei R3 Alleviates Tumor Progression in Mice with Colorectal Cancer. (2023) pubmed
- Lactobacillus paracasei subsp. paracasei 2004 improves health and lifespan in Caenorhabditis elegans. (2024) pubmed
- Lactobacillus paracasei X11 Ameliorates Hyperuricemia and Modulates Gut Microbiota in Mice. (2022) pubmed
- Lactobacillus paracasei HII01 enhances lifespan and promotes neuroprotection in Caenorhabditis elegans. (2023) pubmed
- Lactobacillus paracasei IMC 502 ameliorates type 2 diabetes by mediating gut microbiota-SCFA-hormone/inflammation pathway in mice. (2023) pubmed
- Lactobacillus paracasei JY062 Alleviates Glucolipid Metabolism Disorders via the Adipoinsular Axis and Gut Microbiota. (2024) pubmed